Caprock Group, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
Caprock Group, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$136,899
-19.7%
25,119
-1.2%
0.01%
-23.1%
Q2 2023$170,561
-24.0%
25,4190.0%0.01%
-23.5%
Q1 2023$224,450
+15.6%
25,4190.0%0.02%
-5.6%
Q4 2022$194,201
-0.4%
25,419
-7.0%
0.02%
-5.3%
Q3 2022$195,000
-13.3%
27,338
-1.5%
0.02%
-13.6%
Q2 2022$225,000
-49.9%
27,752
-14.2%
0.02%
-47.6%
Q1 2022$449,000
-54.7%
32,338
-8.5%
0.04%
-48.8%
Q4 2021$992,000
-36.6%
35,338
-23.2%
0.08%
-41.4%
Q3 2021$1,565,000
-16.8%
46,0380.0%0.14%
-18.1%
Q2 2021$1,881,000
-4.7%
46,038
-6.1%
0.17%
-20.8%
Q1 2021$1,974,000
+10.3%
49,038
+61.9%
0.22%
+5.9%
Q4 2020$1,790,000
-9.6%
30,280
-25.6%
0.20%
-24.7%
Q3 2020$1,980,000
-15.1%
40,710
-15.6%
0.27%
-22.6%
Q2 2020$2,332,000
+74.2%
48,2100.0%0.35%
+37.8%
Q1 2020$1,339,000
+492.5%
48,210
+539.6%
0.25%
+535.0%
Q4 2019$226,000
-2.6%
7,538
+0.5%
0.04%
-11.1%
Q3 2019$232,0007,5000.04%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders